F Arnold

Summary

Affiliation: University of Louisville
Country: USA

Publications

  1. ncbi request reprint Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study
    A T Griffin
    Department of Medicine, School of Medicine, University of Louisville, Louisville, Kentucky 40202, USA
    Int J Tuberc Lung Dis 14:495-9. 2010
  2. doi request reprint Mortality differences among hospitalized patients with community-acquired pneumonia in three world regions: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study
    Forest W Arnold
    University of Louisville, School of Medicine, Department of Medicine, Division of Infectious Diseases, 501 E Broadway, Suite 120, Louisville, KY 40292, USA
    Respir Med 107:1101-11. 2013
  3. doi request reprint Outcomes in females hospitalised with community-acquired pneumonia are worse than in males
    Forest W Arnold
    Division of Infectious Diseases, Dept of Medicine, School of Medicine, University of Louisville, Louisville, KY 40292, USA
    Eur Respir J 41:1135-40. 2013
  4. ncbi request reprint An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus
    Forest W Arnold
    University of Louisville School of Medicine, KY 40292, USA
    J Ky Med Assoc 103:206-10. 2005
  5. doi request reprint Predictive accuracy of the pneumonia severity index vs CRB-65 for time to clinical stability: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study
    Forest W Arnold
    University of Louisville, School of Medicine, Department of Medicine, Division of Infectious Diseases, Louisville, KY 40202, USA
    Respir Med 104:1736-43. 2010
  6. doi request reprint Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results
    Forest W Arnold
    Division of Infectious Diseases, Department of Medicine, School of Medicine, University of Louisville, 627 Preston St, Ste 100, Louisville, KY 40202, USA
    Arch Intern Med 169:1515-24. 2009
  7. ncbi request reprint Establishing a hospital program to improve antimicrobial use, control bacterial resistance and contain healthcare costs: the University of Louisville experience
    Forest W Arnold
    Division of Infectious Diseases, Department of Medicine, University of Louisville, KY 40202, USA
    J Ky Med Assoc 105:431-7. 2007
  8. ncbi request reprint Improving antimicrobial use: longitudinal assessment of an antimicrobial team including a clinical pharmacist
    Forest W Arnold
    University of Louisville, Dept of Medicine, Division of Infections Diseases, 512 S Hancock St, Carmichael Bldg, Rm 208E, Louisville, KY 40292, USA
    J Manag Care Pharm 10:152-8. 2004
  9. ncbi request reprint A worldwide perspective of atypical pathogens in community-acquired pneumonia
    Forest W Arnold
    Division of Infectious Diseases, University of Louisville, Louisville, KY 40292, USA
    Am J Respir Crit Care Med 175:1086-93. 2007
  10. ncbi request reprint The pneumonia severity index predicts time to clinical stability in patients with community-acquired pneumonia
    F Arnold
    Division of Infectious Diseases, University of Louisville, Louisville, Kentucky 40292, USA
    Int J Tuberc Lung Dis 10:739-43. 2006

Detail Information

Publications15

  1. ncbi request reprint Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study
    A T Griffin
    Department of Medicine, School of Medicine, University of Louisville, Louisville, Kentucky 40202, USA
    Int J Tuberc Lung Dis 14:495-9. 2010
    ..Data supporting a quinolone or a macrolide as preferred therapy for community-acquired pneumonia (CAP) due to Legionella pneumophila are not firmly established. Some literature suggests a benefit of quinolones over macrolides...
  2. doi request reprint Mortality differences among hospitalized patients with community-acquired pneumonia in three world regions: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study
    Forest W Arnold
    University of Louisville, School of Medicine, Department of Medicine, Division of Infectious Diseases, 501 E Broadway, Suite 120, Louisville, KY 40292, USA
    Respir Med 107:1101-11. 2013
    ..Our objective was to determine if there was a difference in mortality among hospitalized patients with CAP in three continental regions of the world...
  3. doi request reprint Outcomes in females hospitalised with community-acquired pneumonia are worse than in males
    Forest W Arnold
    Division of Infectious Diseases, Dept of Medicine, School of Medicine, University of Louisville, Louisville, KY 40292, USA
    Eur Respir J 41:1135-40. 2013
    ..They are more likely to take longer to reach clinical stability, have longer hospital stays and are 15% more likely to have died after 28 days. Current pneumonia scoring systems may need to be revised regarding female mortality risk...
  4. ncbi request reprint An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus
    Forest W Arnold
    University of Louisville School of Medicine, KY 40292, USA
    J Ky Med Assoc 103:206-10. 2005
    ..Reviewing risk factors in adult patients with CA-MRSA in Kentucky has not been reported...
  5. doi request reprint Predictive accuracy of the pneumonia severity index vs CRB-65 for time to clinical stability: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study
    Forest W Arnold
    University of Louisville, School of Medicine, Department of Medicine, Division of Infectious Diseases, Louisville, KY 40202, USA
    Respir Med 104:1736-43. 2010
    ..It is unknown how well either score predicts time to clinical stability in hospitalized patients with CAP. Thus, it is also not known which score predicts time to clinical stability better...
  6. doi request reprint Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results
    Forest W Arnold
    Division of Infectious Diseases, Department of Medicine, School of Medicine, University of Louisville, 627 Preston St, Ste 100, Louisville, KY 40202, USA
    Arch Intern Med 169:1515-24. 2009
    ....
  7. ncbi request reprint Establishing a hospital program to improve antimicrobial use, control bacterial resistance and contain healthcare costs: the University of Louisville experience
    Forest W Arnold
    Division of Infectious Diseases, Department of Medicine, University of Louisville, KY 40202, USA
    J Ky Med Assoc 105:431-7. 2007
    ....
  8. ncbi request reprint Improving antimicrobial use: longitudinal assessment of an antimicrobial team including a clinical pharmacist
    Forest W Arnold
    University of Louisville, Dept of Medicine, Division of Infections Diseases, 512 S Hancock St, Carmichael Bldg, Rm 208E, Louisville, KY 40292, USA
    J Manag Care Pharm 10:152-8. 2004
    ....
  9. ncbi request reprint A worldwide perspective of atypical pathogens in community-acquired pneumonia
    Forest W Arnold
    Division of Infectious Diseases, University of Louisville, Louisville, KY 40292, USA
    Am J Respir Crit Care Med 175:1086-93. 2007
    ..In different regions of the world, monotherapy with a beta-lactam antimicrobial is common...
  10. ncbi request reprint The pneumonia severity index predicts time to clinical stability in patients with community-acquired pneumonia
    F Arnold
    Division of Infectious Diseases, University of Louisville, Louisville, Kentucky 40292, USA
    Int J Tuberc Lung Dis 10:739-43. 2006
    ..A total of 33 hospitals in 13 countries in North America, Europe, Africa, Asia and Latin America...
  11. ncbi request reprint Improving antimicrobial use in the hospital setting by providing usage feedback to prescribing physicians
    Forest W Arnold
    Division of Infectious Diseases, Department of Medicine, School of Medicine, University of Louisville, 512 South Hancock Street, Louisville, KY 40292, USA
    Infect Control Hosp Epidemiol 27:378-82. 2006
    ..To determine whether feedback on antimicrobial use improves physician compliance with local hospital guidelines on antimicrobial prescribing...
  12. doi request reprint Clinical outcomes of HIV-infected patients hospitalized with bacterial community-acquired pneumonia
    Maricar Malinis
    Division of Infectious Disease, University of Louisville School of Medicine, Louisville, KY, USA
    Int J Infect Dis 14:e22-7. 2010
    ..There are limited and conflicting data on clinical outcomes of community-acquired pneumonia (CAP) among HIV-infected patients...
  13. doi request reprint Incidence of respiratory viruses in patients with community-acquired pneumonia admitted to the intensive care unit: results from the Severe Influenza Pneumonia Surveillance (SIPS) project
    T Wiemken
    Division of Infectious Diseases, University of Louisville, Louisville, KY, USA
    Eur J Clin Microbiol Infect Dis 32:705-10. 2013
    ..The Centers for Disease Control and Prevention (CDC) recommend empiric anti-influenza therapy during the winter for hospitalized patients with CAP. This study supports this recommendation in patients with ICU-CAP...
  14. ncbi request reprint Hospitalization for community-acquired pneumonia: the pneumonia severity index vs clinical judgment
    Forest W Arnold
    Division of Infectious Diseases, Department of Medicine, University of Louisville, Louisville, KY, USA
    Chest 124:121-4. 2003
    ..2) To determine the positive predictive value of the pneumonia severity index as the sole indicator for detecting inappropriate hospitalizations among patients with CAP...
  15. doi request reprint Obtaining routine blood cultures during interleukin-2-containing therapy is unnecessary
    Michael V Jaglal
    Department of Medicine, University of Louisville, Louisville, KY 40202, USA
    Am J Clin Oncol 32:429-31. 2009
    ..To evaluate the usefulness of routine blood cultures in patients who develop temperatures of 38.5 degrees C or higher while treated with interleukin-2 (IL-2)...